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Background: In average-risk individuals aged 50 to 75 years, there is no difference in life-years gained when
comparing colonoscopy every 10 years vs. annual fecal immunochemical testing (FIT) for colorectal cancer screening.
Little is known about the preferences of patients when they have experienced both tests.
Methods: The study was conducted with 954 patients from the University of Iowa Hospital and Clinics during 2010 to
2011. Patients scheduled for a colonoscopy were asked to complete a FIT before the colonoscopy preparation.
Following both tests, patients completed a questionnaire which was based on an analytic hierarchy process (AHP)
decision-making model.
Results: In the AHP analysis, the test accuracy was given the highest priority (0.457), followed by complications (0.321),
and test preparation (0.223). Patients preferred colonoscopy (0.599) compared with FIT (0.401) when considering
accuracy; preferred FIT (0.589) compared with colonoscopy (0.411) when considering avoiding complications; and
preferred FIT (0.650) compared with colonoscopy (0.350) when considering test preparation. The overall aggregated
priorities were 0.517 for FIT, and 0.483 for colonoscopy, indicating patients slightly preferred FIT over colonoscopy.
Patients’ preferences were significantly different before and after provision of detailed information on test features
(p < 0.0001).
Conclusions: AHP analysis showed that patients slightly preferred FIT over colonoscopy. The information provided
to patients strongly affected patient preference. Patients’ test preferences should be considered when ordering a
colorectal cancer screening test.
Keywords: Colorectal cancer screening, Analytic Hierarchy Process (AHP), Patient preference, Colonoscopy, Fecal
immunochemical testBackground
Colorectal cancer (CRC) is the third leading cause of can-
cer death for both men and women in the United States
[1]. Screening for colorectal cancer leads to approximately
a 50% mortality reduction [2]. The American College of
Physicians (ACP) recently reviewed multiple guidelines for
colorectal cancer and recommended that all average-risk
adults 50 years of age or older should be offered any of the
following screening methods: fecal occult blood testing an-
nually, sigmoidoscopy every five years, or colonoscopy* Correspondence: yinghui-xu@uiowa.edu
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unless otherwise stated.every 10 years [3]. Although CRC screening rates have
gradually increased in the past 10 years, one-third of
adults 50 and older still are not up-to-date with CRC
screenings [4]. Individual preferences for a certain
screening test have been found to influence uptake in a
CRC-screening program [5,6]. Incorporating patients’
preferences into the clinical decision-making process
may be a way to improve screening rates.
Colonoscopy is the most popular screening test for colo-
rectal cancer in the United States [7], being a gold stand-
ard for early detection and prevention of colorectal
cancer, even though no studies have shown it to be super-
ior to a sensitive fecal occult blood test in an average-risk
population to reduce morbidity and mortality from CRC.is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sensitive [8,9], and cost-effective than the guaiac test
[10], but is underused in the United States [11]. There
is no difference in life-years gained when comparing a
screening strategy with colonoscopy every 10 years vs.
an annual sensitive fecal occult blood test, such as a
FIT [12]. However, in 2011, the Centers for Disease
Control and Prevention (CDC) reported that only 11.8%
of patients aged 50–75 completed fecal occult blood
tests within the previous year [13]. If we are to improve
CRC screening rates, it would be helpful to obtain
insight into the patient preferences between colonos-
copy and FIT.
Previous studies have described variations in patient
preferences for specific CRC screening tests. These stud-
ies suggest individuals who value accuracy the most are
more likely to select colonoscopy [14], whereas others
preferred fecal occult blood testing because of its lower
complication rate and simpler procedure [6,15]. Re-
cently, several studies [16-19] have applied a method
called the Analytic Hierarchy Process (AHP) to evaluate
patient preferences for CRC screening tests. The unique
contribution of this paper is that we compared patient
preferences for FIT vs. colonoscopy after patients had
completed both tests.
The purposes of this study were to: 1) analyze patient
preferences for colorectal cancer screening between
FIT and colonoscopy; 2) identify the test features that
are important in the decision making; and 3) assess
whether test preferences are associated with patients’
knowledge of the tests. It was anticipated that the in-
formation from this study would improve physician-
patient discussions on screening options and enhance
compliance with colorectal cancer screening.Methods
Recruitment
The study and methods were approved by the University
of Iowa Institutional Review Board and all participants
provided written informed consent.
The study sample was comprised of patients sched-
uled for a colonoscopy at the University of Iowa Hospi-
tals and Clinics. Patients were eligible for the study if
they met the following criteria: 1) adults age 40 to
75 years, 2) scheduled for screening or surveillance col-
onoscopy, 3) colonoscopy scheduled within 10 days to
6 weeks, 4) valid address and telephone number, and 5)
English speaking. Patients were excluded if they met any
of the following: 1) familial polyposis syndromes, ulcera-
tive colitis, or Crohn’s disease; 2) personal history of
colon cancer; 3) active rectal bleeding; 4) change in
bowel habits; or 5) pencil-like stools in the past two
months.Between January 22, 2010 and November 22, 2011, re-
search staff in the Department of Family Medicine at the
University of Iowa identified each patient with a scheduled
colonoscopy from the electronic medical record system,
Epic. A recruitment mailing (including a cover letter, two
informed consents, a single-sample FIT kit, and a postage-
paid return envelope) was sent to 2336 potential partici-
pants. Participants were asked to complete the FIT kit at
home up to the day before they started their colonoscopy
preparation and mail it to the study team. If the informed
consent and FIT were returned, and the colonoscopy was
completed, subjects were mailed a follow-up question-
naire the day after completing the colonoscopy. Non-
responders were reminded by follow-up telephone calls
and second mailings when necessary.
Follow-up questionnaire
The follow-up questionnaire was developed by a group
comprising practicing family physicians, including an ex-
pert in issues concerning medical decision-making (GB).
The information and questions provided in the question-
naire were discussed and revised numerous times after
deliberation. The information was based on the current
CRC screening guidelines, literature, and the website of
the Centers for Disease Control and Prevention. Partici-
pants were aware that if they completed a FIT and the
result were positive, then a colonoscopy would be rec-
ommended (if they chose FIT as a screening in the “real”
world). The final questionnaire developed by the re-
search team consisted of 2 multiple-choice questions
asking patient preference between FIT or colonoscopy; 6
questions related to the AHP model; 3 questions on
preferences with various assumptions for out-of-pocket
costs; 4 questions on personal and family history, and 7
questions on demographics. Patients were first asked
which test they preferred based on the experience of
having had both tests (FIT and colonoscopy). This ques-
tion was a multiple-choice format to allow for patients
to choose one test. Participants then answered the
remaining questions based on the AHP model. The
three main criteria (test accuracy; test complications;
and test preparation, frequency, and procedure) were de-
scribed in detail for each test. Participants then com-
pared the relative importance between each possible pair
of the three test features. They were asked to identify
the more important test feature or whether they were
equally important when selecting a colorectal cancer
screening test. An example of questions follows:
Thinking about each pair of features, which feature is
most important to you? Check one box.
□ Accuracy of the test
□ Avoiding complications
□ Both are equally important
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were requested to choose one answer from the following
3 options:
How much more important?
□ Not very much
□ Somewhat
□ Much more
The participants were then provided with side-by-side
comparison information between FIT and colonoscopy
for each of the three test features (test accuracy; test
complications; and test preparation, frequency and pro-
cedure). Participants repeated the comparison process to
determine their preferences with respect to each test fea-
ture. An example question follows:
Please indicate which test you prefer based on the in-
formation on the accuracy of the test we provided
above. Check one box.
□ FIT every year
□ Colonoscopy every 10 years
□ Either test is fine (no preference for either one)
If they preferred one test over the other, the participants
were requested to choose one answer from the 3 options
of “not very much”, “somewhat”, or “much more”.
After the questions on AHP model, we once again
asked participants which tests they preferred after read-
ing the detailed information on each test provided in the
questionnaire. Patient personal and family history of di-
gestive disease and demographic information such as
age, gender, education, insurance, and income were also
collected.
Analytic Hierarchy Process (AHP)
AHP is a widely used decision-making method devel-
oped by Saaty [20,21] in the 1970s to assist people in
making complex decisions. In the AHP model, the prob-
lem is decomposed into a hierarchy of goal, criteria and
alternatives, with the goal placed at the top, criteriaFigure 1 The structure of the Analytic Hierarchy Process model.placed at the intermediate level and alternatives at the
bottom. The elements in each hierarchical group are
compared as pairs with respect to their importance in
making the decision. These comparisons are used to ob-
tain the proportional weights of the importance of the
criteria and the relative importance of the alternatives in
terms of each individual decision criterion. In the last
step of the process, final priorities are calculated across
the hierarchy for each of the decision alternatives. The
alternative that attains the highest final priority is
thought to be the most suitable decision.
The model used for this study is shown in Figure 1.
The goal of the decision, shown on the top, defined as
“preferred test”, was to determine the patients’ preferences
for colonoscopy or FIT for colorectal cancer screening.
We focused on three test features related to decision-
making in colorectal cancer screening: 1) test accuracy; 2)
frequency of complications; and 3) preparation, frequency
and procedure as the decision criteria for this problem.
The alternatives were comprised of two of the recom-
mended screening tests, colonoscopy every 10 years or an
annual FIT test. The relative importance of three features
was compared by constructing a 3 × 3 matrix of the three
test features for the second level. The two alternatives
were compared with respect to each of the test features as
well, leading to three 2 × 2 matrices for the third level.
The final step was to synthesize the results to obtain the
final priorities of the two screening methods. We multi-
plied each alternative by the priority of its criterion and
added the resulting weights for each alternative to calcu-
late its final priority.
AHP computations and data analysis
The collected data were analyzed with SAS software and
the codes were written specifically for the AHP applica-
tion (YX). The comparison of importance was converted
to a numerical value using a scale of 1 to 4, where 1
meant equal importance (or no preference), 2 “not very
much”, 3 “somewhat”, and 4 “much more important”.
The geometric mean method was used to calculate an
eigenvector for each patient, and the values of the weights
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tio (CR) was calculated for each patient at the second
level. If the CR value was greater than 0.15, the matrix
was considered inconsistent and the patient’s judgments
were excluded [18,22]. We did not calculate the CR at the
third level, because for the matrices of size 2 × 2 the CR is
not applicable, but we excluded patients’ judgments if
they were excluded at the second level. Tables 1 and 2
shows a case of the input data and how the eigenvector
for level 2 and final priorities were calculated. In this case,
the highest weight criterion was “accuracy” (0.625), followed
by “complications” (0.239), and “preparation” (0.136). The
CR was low (0.0559) and it was considered to be a consist-
ent judgment. The final priority of the given alternative
was obtained from the weight of the alternative multiplied
by the priority of each criterion. The final priorities of the
alternatives were “FIT” (0.418) and “Colonoscopy” (0.582)
for this participant, indicating that this patient preferred
colonoscopy every 10 years more than a FIT annually.
While participants acted as separate individuals, the
aggregation of individual priorities was calculated with
an arithmetic mean for synthesizing individual decisions
into a group decision [23].
Demographic characteristics of participants who were
included and excluded in the AHP analysis were sum-
marized. A t-test was used to compare the means of the
continuous variables, and the chi-square test was used
to compare the percentages between two groups. To
evaluate the changes of the patients’ preferences be-
tween FIT and colonoscopy before and after they read
the detailed information in the questionnaire, the SAS
FREQ procedure with the agreement test for symmetry
was used for the comparison. All analyses were per-
formed using SAS, version 9.3 (SAS Institute Inc, Cary,
North Carolina).
Results
As shown in Figure 2, of the potential 2336 patients, 1140
patients returned a consent form and a FIT (49%). A total
of 1090 patients completed a colonoscopy; however, 136
were excluded from analysis for having a diagnostic col-
onoscopy and/or not returning follow-up questionnaire,
leaving 954 patients in the study for analysis. Of the 954
patients, 667 patients (667/954 = 70%) were included in
AHP analysis with consistency ratios (CR) ≤ 0.15. Pa-
tient characteristics of included and excluded patients
in the AHP model are shown in Table 3. The age wasTable 1 A case of the pairwise comparison and priority calcul
Accuracy Complication Preparatio
Accuracy 1 3 4
Complication 1/3 1 2
Preparation 1/4 1/2 1significantly younger in the included patients than that
in the excluded patient (56.7 vs 58.0, p = 0.014). There
were no significant differences between included and
excluded patients for other demographic characteristics
including gender, marital status, race, ethnicity, educa-
tion level, insurance status, income and location. Of the
667 patients included in the AHP analysis, the average
time for returning the follow-up questionnaire after col-
onoscopy was 16.9 (SD 18.3) days. Of these 667 pa-
tients, 59% were female, 71% were married, 93% were
white, and only 1% were Hispanic. Eighty-one percent
had graduated from college or higher. Approximately
65% of patients reported annual household incomes of
$40,000 or more, and most patients reported having
some type of health insurance. Almost two thirds were
from urban areas in Iowa.
Table 4 displays the average priorities for each criterion
at level 2 and the average weights for the two alternatives
with respect to each criterion at level 3. The final column
shows the average of individual final priorities. The aver-
age priorities for the second level criteria of accuracy,
complications, and test preparation were 0.457, 0.321, and
0.223, respectively, indicating that participants considered
accuracy as the most important, followed by complica-
tions, and test preparation. Participants preferred colonos-
copy (0.599) compared with FIT (0.401) with respect to
accuracy; they preferred FIT (0.589) compared with colon-
oscopy (0.411) with respect to avoiding complications;
and preferred FIT (0.650) compared to colonoscopy
(0.350) with respect to test preparation. The average of in-
dividual final priorities for FIT was 0.517, and for colonos-
copy was 0.483, indicating participants had a slight
preference for FIT over colonoscopy overall.
Patients’ preferences from the multiple choice questions
asked directly before and after the provision of detailed in-
formation are displayed in Table 5. Of the 382 subjects
who initially preferred FIT, 222 (58.1%) continued to pre-
fer FIT after information about the test, but 139 (36.4%)
changed their preferences from FIT to colonoscopy.
Among the 130 subjects initially preferring colonoscopy,
114 (87.7%) continued to prefer colonoscopy after infor-
mation about the test, while only 7 (5.4%) changed their
preferences from colonoscopy to FIT. Overall, 391 (61.5%)
subjects kept their preferences the same. The kappa coeffi-
cient was 0.40 (95% CI, 0.34, 0.45), indicating fair agree-
ment before and after the provision of information. The
test for symmetry indicated that patients changed theiration (consistency ratio (CR) = 0.0559)
n Geometric means Normalized priorities
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 3 43p ¼ 2:289 2.289/(2.289 + 0.874 + 0.5) = 0.625
0.874 0.239
0.500 0.136









FIT 0.25 0.667 0.75 0.418
Colonoscopy 0.75 0.333 0.25 0.582
Final priority of FIT = 0.625 × 0.25 + 0.239 × 0.667 + 0.136 × 0.75 = 0.418.
Final priority of Colonoscopy = 0.625 × 0.75 + 0.239 × 0.333 + 0.136 × 0.25 = 0.582.
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formation (p < 0.0001). Patients’ preference priorities
through the AHP model and from the directly-asked
question after the provision of information were also
compared. The kappa coefficient was 0.57 (95% CI, 0.51,
0.62), indicating moderate agreement between the two
formats for obtaining preferences. The test for sym-
metry indicated that there were significant differences
between the two formats for preferences (p < 0.0001).
Preferences were also elicited under hypothetical out-
of-pocket costs. Under the assumption the same out-of-
pocket costs for both tests, 43% preferred to be screened
by FIT, colonoscopy was preferred by 42%, and 15% felt
either test would be fine. When assuming an out-of-
pocket cost of $40 for FIT and $4000 for colonoscopy,Figure 2 Participant enrollment flow chart.preferences changed significantly (p < 0.0001 by the test
for symmetry): 77% preferred to be screened by FIT, col-
onoscopy was preferred by 17%, and 6% felt either test
would be fine.
There was no significant association between patients’
preference priories and their race, marital status, insur-
ance, or rural/urban residency. Females were more
likely to prefer annual FIT than males, 54% vs 43%, re-
spectively, p = 0.011. About 28% patients with an educa-
tion of high school or less indicated equal priorities
between annual FIT and colonoscopy compared to 11%
for those with college or higher education, p < 0.01. The
preference priorities also varied by household income.
As household incomes increased, patients tended to
prefer colonoscopy. The percent preferring colonoscopy
for those household income less than $40,000, $40,000
to $80,000, and greater than $80,000 were 34%, 46%,
and 51%, respectively, p < 0.01.
Discussion
To our knowledge, this is the first study to measure prefer-
ences for CRC screening methods with patients who had
immediate prior experience with both the colonoscopy and









Age in years (SD) 56.7 (7.4) 58.0 (7.4) 0.0135
Gender 0.3476
Female 399 (59.9%) 162 (56.6%)
Male 267 (40.1%) 124 (43.4%)
Marital Status 0.6326
Single 166 (24.9%) 65 (22.8%)
Married 468 (70.3%) 203 (71.2%)
Widowed 32 (4.8%) 17 (6.0%)
Race 0.9115
White 617 (93.1%) 268 (94.4%)
Black 17 (2.6%) 6 (2.1%)
Asian 17 (2.6%) 7 (2.5%)
American Indian 3 (0.5%) 1 (0.4%)
Others 9 (1.4%) 2 (0.7%)
Ethnicity 0.6120
Hispanic 7 (1.1%) 4 (1.4%)
Education level 0.1134
High school or less 112 (16.8%) 64 (22.3%)
Some college or higher 552 (82.8%) 221 (77.0%)
Insurance status
Private 446 (67.2%) 186 (65.5%) 0.6161
Medicaid/Iowa Care 129 (19.4%) 59 (20.8%) 0.6338
Medicare 110 (16.6%) 53 (18.7%) 0.4334
None 12 (1.8%) 7 (2.4%) 0.5165
Annual income 0.7372
< $40,000 204 (30.6%) 88 (30.7%)
$40,000 to < $80,000 169 (25.3%) 80 (27.8%)
≥ $80,000 266 (39.9%) 105 (36.6%)
Unreported 28 (4.2%) 14 (4.9%)
Rurality 0.2249
Rural 217 (32.5%) 105 (36.6%)
Urban 450 (67.5%) 182 (63.4%)





Alternatives 0.457 0.321 0.223
Colonoscopy 0.599 0.411 0.350 0.483*
FIT 0.401 0.589 0.650 0.517*
*The final priorities were averages based on the individual final priorities.
Table 5 Subjects’ preference for colon cancer screening




















256 (40.3%) 295 (46.4%) 85 (13.4%) 636
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ing options was a complex decision problem because each
option presented advantages and disadvantages. In the
present study, we used a large cohort of patients who were
scheduled for colonoscopy. We demonstrated in the AHP
model that patients value accuracy more highly than test
complications and preparation. Overall, patients slightly
preferred annual FIT over colonoscopy.
In this study, the decision-making process in the colon-
oscopy screening choices was conducted with a question-
naire based on AHP. The difficulty and confusion forpatients to make a choice consistent with their values and
preferences for colon cancer screening has been recog-
nized [24]. AHP has the distinct advantage in that it de-
composes a complex decision problem into a hierarchical
structure of the criteria, which provides patients with a
better focus on specific criteria and sub-criteria when de-
termining priorities. It allows patients to make adequate
judgments in a pairwise fashion, and the pairwise compar-
isons are straightforward and convenient. It provides a
mechanism to check inconsistencies among the different
pairwise comparisons by computing the consistency ratio.
In our study using the AHP method, we not only quanti-
fied the relative importance of specific test features, but
also computed relative weights for the alternatives in re-
gard to each of the test features. Not surprisingly, there
were some discrepancies in the preferences through the
AHP model and from the directly-asked question. Patients
answered the directly-asked questions intuitively. It is dif-
ficult for patients to make consistent decisions when faced
with unfamiliar problems involving trade-offs between the
advantages and disadvantages. The AHP was designed to
help them make more informed choices in a step-by-step
manner. On the other hand, investigators need sufficient
knowledge and understanding of the problem being exam-
ined in order to successfully structure the AHP model and
include all of the elements in the model with accuracy.
The validity of the AHP process has been extensively
tested in the well-designed models [25].
Our findings are consistent with other studies [5,26-30]
that indicate a fairly close preference between colonoscopy
and FIT as options for colorectal screening. However,
other studies used qualitative ratings and ranking survey
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fer each of the CRC tests. A few studies [16-18] have used
the AHP method to study preferences and priorities re-
garding colorectal cancer screening. Dolan et al. [17,18]
indicated that patient priorities varied widely and cannot
be predicted using demographic factors, numeracy, or lit-
eracy skills. Katsumura and colleagues [16] found that
subjects gave higher priority to colonoscopy than to FOBT.
However, this study was conducted in Japan among inter-
net users, in a group of subjects who may have attained
higher levels of education and annual household income.
These studies illustrated the importance of identifying pa-
tients’ preferences in choosing among currently recom-
mended colorectal cancer screening options. However, in
these studies, subjects had not had the experience of com-
pleting both a colonoscopy and FIT, and our study is
unique in that our questionnaires were conducted after
subjects had experienced both tests and thus patients could
factor their experience into their knowledge of the tests.
Previous studies consistently reported that colonoscopy
and the stool blood test were the most often-preferred op-
tions by patients [5,30]. The number of colonoscopy proce-
dures has risen steadily in the United States [13] because
of its advantages, such as accuracy, sensitivity, allowing
diagnosis and therapy in one session, and a longer interval
between tests if no abnormal findings. The number of
FOBTs performed annually decreased gradually from
21.1% to 11.8% between 2002 and 2010 [13]. Primary care
physicians tend to recommend colonoscopy over other
screening tests regardless of a patient’s preference. Hawley
et al. [5] found 49% of the patients preferred to make med-
ical decisions themselves, only 10% of the patients favored
having a physician make their medical decisions. A recent
study by Inadomi and colleagues [31] tested the patient-
centered approach in 1000 patients who were randomized
into three arms: FOBT only, colonoscopy only, or a choice
of either test. Participants who were offered only colonos-
copy completed the screening at a significantly lower rate
(38%) than those who were offered FOBT (67%) or given a
choice of either test (69%). This study indicates that not
permitting a patient to choose their colorectal cancer
screening test may contribute to non-compliance and po-
tentially a screening failure. On the other hand, presenting
multiple options for CRC screening may increase patient
confusion and as a result, patients may fail to be screened
[24]. The psychology literature has noted that too many
choices constitute a barrier to decision-making and lead
people simply to make no choice at all [32]. Our findings
of the fairly close preference between colonoscopy and FIT
have implications for clinicians that they could offer either
of the tests and present the advantages and disadvantages
of each when discussing CRC screening. Patients should be
made aware of the advantages of FIT (sample collected in
the privacy of one’s home, no dietary or other restrictions,no test preparation, no complications) and that no studies
have shown colonoscopy is better than a sensitive fecal
occult blood test for average risk individuals to reduce mor-
bidity and mortality from CRC. A decision modeling ana-
lysis showed no difference in life-years gained between a
strategy of annual fecal immunochemical testing and colon-
oscopy every 10 years [12]. In addition, many European
countries, Great Britain, and Australia have a program of
biennial fecal occult blood testing and reserve colonoscopy
for those with positive fecal occult blood tests [33-36].
Our results confirmed that test preferences were asso-
ciated with the importance of the test features deter-
mined by the patients. Our results using AHP analysis
method were consistent with those studies that found
patients valued accuracy as more important [27,37,38],
and test preparation as the least important. In our study,
when patients considered the accuracy, they were more
inclined to select colonoscopy; when they considered
test preparation or test complications, they favored FIT.
It is important for physicians to identify a particular pa-
tient’s values regarding these test features, and to adopt
a shared decision-making approach when discussing
screening options.
Earlier studies [27,30] reported the association between
race/ethnicity, education level, and income. Patients of
non-Latino ethnicity, those with higher household in-
comes and higher education were more likely to prefer
colonoscopy, but did not find association between test
preferences and gender. We found that patient priorities
differed by gender, education level, and household income.
More women preferred FIT over colonoscopy and those
with higher household incomes tend to prefer colonos-
copy. Our results indicate that physicians should also
consider individual patient’s demographic characteristics
during the shared decision-making process.
In our study, we found that 30% patients provided in-
consistent responses on the AHP questions. One possible
reason that we had a relatively high percentage of patients
with inconsistent responses was because all patients com-
pleted the questionnaire on paper and mailed them to us.
We were not able to have the opportunity to provide
feedback and correct substantially inconsistent judg-
ments. This highlights the need to develop clinically feas-
ible decision-support tools that can provide feedback for
inconsistent responses to facilitate this decision-making
process.
The comparison between patients’ preferences before
and after the information was provided showed the sig-
nificant impact that the information provided had on a
patient’s preferred screening method. In the present
study, the provision of the screening information chan-
ged the preferred screening method for 38% of the sub-
jects. The percent of changing preference was low in the
group which chose colonoscopy initially (12%) compared
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possible explanation could be that patients may learn
that colonoscopy provides more accurate results with a
longer test interval and hence switch their preferences
to colonoscopy. Although patients had experience with
both tests, and this experience provided them with an
understanding of the testing procedures, it is likely that
some patients still lack sufficient knowledge of the test
accuracy, the testing interval, and possible complica-
tions. Previous studies have shown that patients should
be well informed about test information and be involved
in the decision-making process [16]. The provision of in-
formation in influencing an initial choice highlights the
importance of educating patients with the strengths and
limitations of each screening option.
This study has several limitations. We implemented
our study at a Midwestern academic medical center
using an advanced electronic medical record system; our
findings may not apply to less structured settings. Our
sample was limited to mostly well-educated, white pa-
tients with insurance who were scheduled for colonos-
copy screening or surveillance. Future research in a
more racially diverse area should be completed, since
preferences may vary by educational and socioeconomic
levels. Although we asked some questions concerning
cost, our study did not include cost among the test fea-
tures in the AHP model. Our results from the two hypo-
thetical out-of-pocket cost questions were consistent
with two previous studies [39,40] on CRC screening
preferences that indicated that the out-of-pocket costs
can affect preferences. Patients who value out-of-pocket
expenses as an important factor in their decision-making
might have been more inclined to choose the FIT. Our
study offered the FIT at no cost to patients, and this
might have influenced patient preferences toward FIT.
We excluded the 30% of subjects whose responses were
inconsistent, and subjects were significantly older in the
group whose responses were excluded.Conclusions
In summary, we have found that average-risk patients who
experienced both colonoscopy and FIT tests did not have
a distinct preference between FIT and colonoscopy for
screening. We confirmed that patients prioritized accuracy
over other features and their preferences can be linked to
test features. Primary care physicians should discuss with
patients the risks and benefits of screening tests for colo-
rectal cancer, even though it is not possible to discuss all
aspects of screening in a busy clinic setting. The discus-
sions could focus on comparing the main test features of
FIT and colonoscopy. Additional research to determine
the role of the AHP model on the healthcare decision
making is necessary.Abbreviations
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